62
In band
Moving averages
SMA 200$4.74+55.06%
Company profile
ATAI Life Sciences is a pharmaceutical company that is developing psychedelics, other hallucinogens, entactogens, and related drugs for treatment of psychiatric conditions. It was founded in 2018 and is headquartered in Berlin, Germany.
SectorHealthcare
IndustryBiotechnology
Market cap$2.73B
P/E ratioNone
EPS$-2.79
Beta1.552
52-week high$7.45
52-week low$3.27
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 48
VRTX
Vertex Pharmaceuticals Inc
RSI 46
CRSP
CRISPR Therapeutics AG
RSI 47
IOVA
Iovance Biotherapeutics Inc
RSI 73
MRNA
Moderna Inc
RSI 72
VKTX
Viking Therapeutics Inc
RSI 40
SRPT
Sarepta Therapeutics Inc
RSI 43
EDIT
Editas Medicine Inc
RSI 56
IBRX
ImmunityBio Inc
RSI 67
NVAX
Novavax Inc
RSI 68
RSI alerts for ATAI
Get an email the moment ATAI Life Sciences BV crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 13 September 2026 at 11:00 AM EDT